Compare CDMOs with oral solid dose manufacturing capabilities for tablets, capsules, and modified-release products. Filter by batch size, coating technology, and regulatory approvals.
364 companies listed
Tablets and capsules are the workhorse of pharma, roughly 60% of all drug products, so "oral solid dose CDMO" returns a crowded field. The differences that matter are technical, not marketing. Your API's flow and compressibility decide the granulation route: direct compression if it behaves, wet or dry granulation if it doesn't. A shop built for high-shear wet granulation isn't automatically the right home for a moisture-sensitive compound that needs roller compaction. Then there's scale. A CDMO that runs elegant 5,000-tablet clinical batches may not hold content uniformity at two million tablets a day. Heading toward extended- or delayed-release? Confirm the coating and multiparticulate expertise before you commit. Potent compound? Check the containment band (OEB) of the suite you'd actually run in. 364 CDMOs here list oral solid dose. Filter by batch size, coating technology, and regulatory market.
Oral solid dose (OSD) manufacturing is the highest-volume pharmaceutical manufacturing segment. Tablets and capsules account for approximately 60% of all drug products. The manufacturing process includes blending, granulation (wet or dry), compression or encapsulation, coating, and packaging. CDMOs range from small clinical-batch specialists to high-volume commercial manufacturers producing millions of units per day.
Modified-release technologies differentiate premium OSD CDMOs. Extended-release, delayed-release, and pulsatile-release formulations require specialized equipment and expertise in polymer coating, matrix systems, osmotic delivery, and multiparticulate approaches (pellets in capsules). These formulations improve patient compliance and can extend product lifecycle.
India
Bliss GVS Pharma Ltd. is an Indian pharmaceutical company and the world's largest manufacturer of suppositories and pessaries, operating in 60+ international markets. The company operates six manufacturing units in Maharashtra and Daman with WHO-GMP and EU-GMP (PIC/S) approvals, producing suppositories, pessaries, tablets, dry syrups, dry powder injectables, ointments, creams, and gels. Bliss GVS offers contract manufacturing (CMO/CDMO) services alongside its own product portfolio.
Portugal
Bluepharma is a Portuguese CRDMO with over 55 years of experience, offering an integrated approach from R&D through to commercial manufacturing of medicines. The company produces 2 billion units of oral solid pharmaceutical forms and has an industrial plant for high potency products. Bluepharma's facilities are EMA/Infarmed and FDA approved, and the company has expanded into advanced therapies beyond small molecules.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.